Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
10/2013
10/24/2013US20130281695 Intermediates of sitagliptin and preparation process thereof
10/24/2013US20130281690 Isoxazolo-pyridine derivatives
10/24/2013US20130281474 Fused tricyclic inhibitors of mammalian target of rapamycin
10/24/2013US20130281460 6-thio-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
10/24/2013US20130281459 Heteroaromatic Aryl Triazole Derivatives as PDE10A Enzyme Inhibitors
10/24/2013US20130281440 Ddx3 as a biomarker for cancer and methods related thereto
10/24/2013US20130281439 Tosylate salt of cyclopropanecarboxylic acid 4-(6-chloro-3-methyl-4, 10-dihydro-3h-2,3,4,9-tetrabenzo[f]azulene-9-carbonyl)-2-fluorobenzylamide
10/24/2013US20130281438 2,4-DIAMINO-6,7-DIHYDRO-5H-PYRROLO[2,3]PYRIMIDINE DERIVATIVES AS FAK/Pyk2 INHIBITORS
10/24/2013US20130281433 Therapeutic compounds
10/24/2013US20130281432 Pyridinones/pyrazinones, method of making, and method of use thereof
10/24/2013US20130281430 Amino-Indolyl-Substituted Imidazolyl-Pyrimidines and Their Use as Medicaments
10/24/2013US20130281429 2,4-diamino-pyrimidines as aurora inhibitors
10/24/2013US20130281403 Compounds and compositions for the treatment of parasitic diseases
10/24/2013US20130281389 Novel drug targets to overcome de novo drug-resistance in multiple myeloma
10/24/2013US20130280233 Cbp/catenin antagonists for enhancing asymmetric division of somatic stem cells
10/24/2013CA2850881A1 Benzothiazol- 6 -yl acetic acid derivatives and their use for treating an hiv infection
10/23/2013EP2651951A1 Tricyclic pi3k inhibitor compounds and methods of use
10/23/2013EP2651950A1 6 substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
10/23/2013EP2651949A1 Substituted pyrimido[1,2-b]indazoles and their use as modulators of the pi3k/akt pathway
10/23/2013EP2651948A1 Imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment hyperproliferative disorders
10/23/2013EP2651947A1 6-thio-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
10/23/2013EP2651946A1 2-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
10/23/2013EP2651945A1 6-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
10/23/2013EP2651944A1 Substituted 6-imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
10/23/2013EP2651934A1 Imidazopyridines as respiratory syncytial virus antiviral agents
10/23/2013EP2651932A1 Bicyclic ring system substituted sulfonamide functionalised phenols as medicaments
10/23/2013EP2651891A1 Bicyclic ring system substituted amide functionalised phenols as medicaments
10/23/2013EP2651417A1 Ask1 inhibiting pyrrolopyrimidine derivatives
10/23/2013EP2651222A1 Bicyclic triazole and pyrazole lactams as allosteric modulators of mglur5 receptors
10/23/2013CN103370322A 2-substituted imidazopyrazines for use as MPS-1 and TKK inhibitors in the treatment of hyperproliferative disorders
10/23/2013CN103370321A Substituted pyrimido[1,2-b]indazoles and their use as modulators of the PI3K/AKT pathway
10/23/2013CN103370320A Arylaminoalcohol-substituted 2,3-dihydroimidazo[1,2-c]quinolines
10/23/2013CN103370319A Novel coelenterazine substrates and methods of use
10/23/2013CN103370318A Substituted imidazopyridazines
10/23/2013CN103360399A 6-aryl-substituted-imidazole-[1,2-b]pyridazine derivative and preparation method and application thereof
10/23/2013CN103360398A Triazolopyrimidine HIV-1 retrovirus inhibitor and its preparation method and application thereof
10/23/2013CN103360397A Bithienyl pyrrolopyrroledione-naphthyl conjugated derivative as well as preparation method and application thereof
10/23/2013CN103360396A Method for preparing ticagrelor
10/23/2013CN103360395A Indole carbazole compound as well as preparation method and application thereof
10/23/2013CN103360379A Novel oxazolidinone compound
10/23/2013CN102477038B New lactim compound possessing cardiotonic action, its preparation method and its purpose
10/23/2013CN102276615B Method for preparing (-)-5-N-formalardeemin
10/23/2013CN102276613B Sesquiterpene alkaloid compound as well as preparation method and application thereof
10/23/2013CN101723949B Polycyclic agents for treatment of respiratory syncytial virus infections
10/22/2013US8563718 Thiazolyl-pyrazolopyrimidine compounds as synthetic intermediates and related synthetic processes
10/22/2013US8563712 Hydroxy-substituted gold(III) porphyrin complexes as histone deacetylase inhibitors
10/22/2013US8563565 Pyrazoloquinoline derivatives
10/22/2013US8563563 Inhibitors of bruton's tyrosine kinase
10/22/2013US8563561 3-(3-pyrimidine-2-yl-benzyl)-[1,2,4] triazolo[4,3-b]pyrimidine derivatives
10/22/2013US8563560 Preparation of bicyclic guanidine salts in an aqueous media
10/22/2013US8563546 Heterocyclic nitrogenous or oxygenous compounds with insecticidal activity formed from dialdehydes and their preparation and uses thereof
10/22/2013US8563545 Compound useful for the treatment of degenerative and inflammatory diseases
10/22/2013US8563542 Pyrimidine derivatives as protein kinase inhibitors
10/22/2013US8562944 PAA nanoparticles for enhancement of tumor imaging
10/22/2013CA2743030C 3-aminocyclopentanecarboxamides as chemokine receptor modulators
10/22/2013CA2607572C Phthalocyanine derivatives, process for their preparation, pharmaceutical compositions containing them, and their use
10/22/2013CA2551778C Imidazo[1,2-c]pyrimidinylacetic acid derivatives
10/17/2013WO2013155465A1 Substituted xanthine derivatives
10/17/2013WO2013154878A1 Heterocyclic compounds and uses thereof
10/17/2013WO2013154325A1 Novel organic electroluminescent compounds and organic electroluminescent device containing the same
10/17/2013WO2013153539A1 Tricyclic compounds as tec kinase inhibitors
10/17/2013US20130274469 Isoxazolo-pyridine derivatives
10/17/2013US20130274468 Isoxazolo-pyridine derivatives
10/17/2013US20130274466 Process for the preparation of tetracyclic derivatives and intermediate products used in the process
10/17/2013US20130274278 Iap inhibitors
10/17/2013US20130274274 Substituted pyridopyrimidine compounds and their use as flt3 inhibitors
10/17/2013US20130274268 New bicyclic compound for modulating g protein-coupled receptors
10/17/2013US20130274266 5,6-DIHYDRO-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE)
10/17/2013US20130274257 Substituted heterocycles as janus kinase inhibitors
10/17/2013US20130274250 NOVEL ANTIFUNGAL 5,6-DIHYDRO-4H-PYRROLO[1,2-a][1,4]-BENZODIAZEPINES AND 6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINES SUBSTITUTED WITH BENZENE DERIVATIVES
10/17/2013US20130274220 Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase
10/17/2013US20130273037 Compounds and methods for antiviral treatment
10/17/2013DE102012007529A1 New imido-s-heptazine derivatives useful as flame retardants for plastics, textiles, wood products, paper, cardboard, plaster, insulation and building material composites and for producing e.g. luminescent dyes, and optical brightener
10/16/2013EP2650299A1 Crystalline salts of sitagliptin
10/16/2013EP2650298A1 Crystalline salts of sitagliptin
10/16/2013EP2650297A1 Crystalline salts of sitagliptin
10/16/2013EP2650296A1 Crystalline salts of sitagliptin
10/16/2013EP2650295A1 Alpha helix mimetics and methods relating thereto
10/16/2013EP2650294A1 Inhibitors of Bruton's Tyrosine Kinase
10/16/2013EP2650293A1 [1,2,4]triazolo[4,3-b][1,2,4]triazine compound, preparation method and use thereof
10/16/2013EP2650286A1 Quinazoline derivatives and therapeutic use thereof
10/16/2013EP2649077A1 Hiv integrase inhibitors
10/16/2013EP2649076A1 Macrocyclic inhibitors of flaviviridae viruses
10/16/2013EP2649075A1 Substituted pyrazolopyrimidines as glucocerebrosidase activators
10/16/2013EP2649074A1 Hiv integrase inhibitors
10/16/2013EP2649073A2 Process for the preparation of semiconductor materials, compounds and their use
10/16/2013EP2649065A1 Bicyclic compounds as pim inhibitors
10/16/2013EP2649051A1 6-amino-2-phenylamino-1h-benzimidazole-5-carboxamide- derivatives and their use as microsomal prostaglandin e2 synthase-1 inhibitors
10/16/2013EP2648754A2 Methods of inhibiting metastasis from cancer
10/16/2013EP2648735A2 Granzyme b inhibitor compositions, methods and uses for promoting wound healing
10/16/2013EP2648517A1 Tricyclic heterocycles useful as dipeptidyl peptidase-iv inhibitors
10/16/2013EP2648511A1 Pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
10/16/2013CN103351399A Synthesis and separation method for trans cucurbit[6]uril
10/16/2013CN103351392A Synthetic method and synthetic product of symmetric eight methyl cucurbit[6]uril
10/16/2013CN103351391A Compound serving as dipeptidyl enzyme inhibitor, composite of compound, and applications of compound and composite
10/16/2013CN102382116B Synthesis technology and equipment of tetraaryl cobalt porphyrin
10/16/2013CN102272134B Modulators of toll-like receptors
10/16/2013CN102250099B Non-peptide thrombin inhibitors as well as preparation method and medical application thereof
10/16/2013CN101146812B Optically active ammonium salt compound, production intermediate thereof and method for producing same
10/15/2013US8557996 Heteroaryl-substituted alkyne compounds and method of use
1 ... 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 ... 573